Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Other financing activities (2022 - 2025)

Historic Other financing activities for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to -$25.0 million.

  • GE HealthCare Technologies' Other financing activities fell 31666.67% to -$25.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$81.0 million, marking a year-over-year decrease of 13823.53%. This contributed to the annual value of -$81.0 million for FY2025, which is 13823.53% down from last year.
  • GE HealthCare Technologies' Other financing activities amounted to -$25.0 million in Q4 2025, which was down 31666.67% from -$41.0 million recorded in Q3 2025.
  • In the past 5 years, GE HealthCare Technologies' Other financing activities ranged from a high of $7.0 million in Q1 2024 and a low of -$41.0 million during Q3 2025
  • Over the past 4 years, GE HealthCare Technologies' median Other financing activities value was -$17.5 million (recorded in 2022), while the average stood at -$16.0 million.
  • Its Other financing activities has fluctuated over the past 5 years, first surged by 11666.67% in 2023, then tumbled by 120000.0% in 2024.
  • Quarter analysis of 4 years shows GE HealthCare Technologies' Other financing activities stood at -$3.0 million in 2022, then plummeted by 733.33% to -$25.0 million in 2023, then skyrocketed by 76.0% to -$6.0 million in 2024, then tumbled by 316.67% to -$25.0 million in 2025.
  • Its last three reported values are -$25.0 million in Q4 2025, -$41.0 million for Q3 2025, and -$9.0 million during Q2 2025.